Subscribe Now Subscribe Today
Research Article

Evaluation of Natural Compound as a Potential Drug Against DENV Non-structural Proteins: In silico Study

Akhilesh Upgade, Anusha Bhaskar and P. Kumarasamy
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Dengue fever is one of the most threatening epidemics of this era and there is no targeted vaccine and therapy. The present study was designed to elucidate the natural compounds as therapeutic targets for dengue virus. In this study, it is proposed that target approach for dengue drug discovery based on natural ligands obtained from plant extract of C. papaya. Nonstructural proteins were retrieved from the protein data bank and natural compounds were drawn using drawing tool, before docking. All of them were subjected to drug and absorption distribution metabolism toxicity analysis which shows satisfying results which leads to docking studies. Series of 8 compounds have been screened and docked for binding energy prediction and on the basis of lowest binding energy, the potential ligands like 2-Methoxy-4-vinylphenol, 9-Octadecyne and 9, 12, 15-Octadecatrienoic acid, (Z, Z, Z) are recommended for further studies.

Related Articles in ASCI
Similar Articles in this Journal
Search in Google Scholar
View Citation
Report Citation

  How to cite this article:

Akhilesh Upgade, Anusha Bhaskar and P. Kumarasamy, 2014. Evaluation of Natural Compound as a Potential Drug Against DENV Non-structural Proteins: In silico Study. Asian Journal of Biochemistry, 9: 131-141.

DOI: 10.3923/ajb.2014.131.141

Received: June 14, 2013; Accepted: March 07, 2014; Published: May 13, 2014


Dengue shock syndrome is the alarming threat worldwide. It is caused by airborn flavivirus transmmited through female mosquitoes. Increasing technology and urban development allows this epidemic condition to grow and transmit. Human to human transmision dramatically increase the risk. Very recent estimate in middle and South India approximately 500 cases met with drastic fate. Only symptomatic treatment is available to deal with the disease. Understanding the mechanism and mode of viral replication cycle is neccesary for target identification. Totally four serotypes existed among these, depending on severity, they are classified by WHO (2009) and Bhattacharjee and Bhattacharjee (2011).

The pathogenesis of severe Dengue Hemorrhagic Fever (DHF) is still at nascent stage, no vaccine is yet available for inhibition and the vector control measures are not promising. Dengue virus was isolated in India in 1944 but there are very few research centres involved in the core pathogenesis mechanism finding, drug discovery and development is also the tedious process until the mechanism is explained (Gupta et al., 2012). The natural herbal therapies have been tried against such an unknown infections since ancient times in India. Targets were selected from most prevalent strains of DENV2. Full genome of the dengue shows that the virus has structural and non-structural proteins; among this non-structural (NS) enzymes of the replication complex include the NS3 protease and with its NS2B, cofactor, the NS3 helicase/nucleoside triphosphatase (NTPase)/RNA 5’ triphosphatase (RTPase) and the NS5 methyltransferase/RNA-dependent RNA polymerase. Murthy et al. (1999), Erbel et al. (2006), Augustine Ocloo et al. (2012) hence these proteins were selected as target for the study.

The need of the hour is to develop natural antiviral drugs for dengue. Previously published data and evidences say local plant extract of C. papaya having the inhibitory effects on dengue, without scientific background. Papaya is also called “pawpaw” in English an herbaceous succulent plants that posses self supporting stems. Extensive research has been done on the medicinal properties of the leaves of Papaya and has found to be more effective as a antiseptic, blood purifier like biological activities (Gross, 2003; Ayoola and Adeyeye, 2010).

On the base of literature, this pilot study was aimed to evaluate the medicinal natural of compounds from C. Papaya and to study their in silico antiviral activity using docking studies.


Preparation of protein structure: Selected 3 protein targets were downloaded from database Protein Data Bank (PDB). (PDB: All water molecules were removed and on final stage hydrogen atoms were added to receptor molecule before docking.

Preparation of ligand structure: Total 8 important natural compounds available in the plant extract of C. papaya were selected on the basis of their biological activity reported. Structures of the phytochemicals were drawn using Chemsketch drawing tool and saved as structure data format.

Protein ligand interaction: Target proteins were then carried out for binding site studies for better understanding of interaction among the small and large molecules. This interaction is based on the geometry of target and flexibility of the ligand.

ADMET analysis: Small molecules obtained from the plant material are always screened for the potential drug like activity predictions, in this study all the compounds were screened for the drug likeness calculation using the pre-ADMET software (Lipinski et al., 1997).

Absorption, Distribution, Metabolism and Excretion (ADME) were screened to analyse the drug like properties of the phytocompounds, calculation was performed by using the admet-SAR tool. SMILES of ligand were used as input and using the module different parameters were calculated such as blood brain barrier, aqueous solubility, metabolism and carcinogenicity (Cheng et al., 2012).

Computational docking studies: Docking calculations were carried out using Docking Server (Bikadi and Hazai, 2009). Gasteiger partial charges were added to the ligand atoms. Non-polar hydrogen atoms were merged and rotatable bonds were defined. Docking calculations were carried out on protein model. Essential hydrogen atoms, Kollman charges and salvation parameters were added affinity (grid) maps of 23 Å grid points and 0.375 Å spacing were generated using the auto grid program. Auto Dock parameter set-and distance-dependent dielectric functions were used in the calculation of the van der waals and the electrostatic terms, respectively.

Docking simulations were performed using the Lamarckian Genetic Algorithm (LGA) and the Solis and Wets local search method (Solis and Wets, 1981). Initial position, orientation and torsions of the ligand molecules were set randomly. All rotatable torsions were released during docking. Each docking experiment was derived from 10 different runs that were set to terminate after a maximum of 250,000 energy evaluations. The population size was set to 150. During the search, a translational step of 0.2 Å and quaternion and torsion steps of 5 were applied.


Three-dimensional structures of all the three proteins of DENV2 were downloaded from PDB shown in Table 1.

The GCMS analysis results of the plant gives some important phytochemicals (data not shown) which were selected for the docking purpose, structure and details given in Table 2.

ADMET analysis shows aqueous solubility of all compounds. Citronellyl butyrate and 9 octadecyne show level of good solubility. The Blood Brain Barrier (BBB) analysis generally used for penetration studies and in this study all the compounds except 2-Methoxy-4-vinylphenol and L-Arabinitol shows high penetration levels which mean they can cross the barrier and acts on Central nervous system. Cytochrome P (CYP450) is the important for drug metabolism.

Table 1: Protein retrieved from PDB

Table 2: Isolated phytochemicals from C. papya used as a ligand

In this study, N-Aminomorpholine and 9-Octadecyne shows qualifies the test for inhibition. On the otherhand Citronellyl butyrate found to be more lethal due to its carcinogenic activity (Table 4 and 5).

In docking studies, NS3 and NS5 non-structural proteins were found to be more targeted by ligand, shows lowest binding energies, 2-Methoxy-4-vinylphenol, 9,12,15-Octadecatrienoic acid, (Z,Z,Z), 9-Octadecyne shows less binding energy less than -4.0 kcal mol-1 i.e., (-6.15) kcal mol-1 etc., scores shown in Table 3. While docking interaction of ligand with respective proteins shown in Fig. 1-3(a-h).

Table 3: Protein ligand interaction docking scores

Fig. 1(a-h):
NS3 protein docked with following ligand (a) 9, 12, 15-Octadecatrienoic acid, (Z, Z, Z) (b) 9 Octa decayne, (c) Citronyll butyrate, (d) 4-Hydroxybenzyl alcohol, bis(pentafluoropropionate), (e) 2-Methoxy-4-vinylphenol (f) L-Arabinitol and (g) Phytol and (h) N-Aminomorpholine

Fig. 2(a-h):
NS5 protein docked with following ligand (a) Citronyll butyrate, (b) 2-Methoxy-4- vinylphenol, (c) 9, 12, 15-Octadecatrienoic acid, (Z, Z, Z), (d) N-Aminomorpholine, (e) 9-Octa decayne, (f) Phytol, (g) L-Arabinitol and (h) 4-Hydroxybenzyl alcohol bis(Pentafluoropropionate)

Table 4: ADMET Properties of the compounds

Fig. 3(a-h):
NS2+NS3 complex protein docked with following ligand (a) 4-Hydroxybenzyl alcohol, (b) 9-Octa decayne bis(Pentafluoropropionate), (c) L-Arabinitol, (d) Citronyll butyrate, (e) 2-Methoxy-4-vinylphenol, (f) 9, 12, 15-Octadecatrienoic acid, (Z, Z, Z), (g) N-Aminomorpholine and (h) Phytol

Table 5: ADME analysis values


Eight naturally available compounds were critically evaluated against target and for drug likeliness activity using different parameters. Analysis shows that all compounds are suitable for the drug Lipinski Rule Five, but out of 8 and 3 compound such as 2-Methoxy-4-vinylphenol, 9,12,15-Octadecatrienoic acid, (Z,Z,Z) and 9 octadecyne were strictly qualifies the parameters which can refer the compound as a drug molecule.

There are number of recent high quality research reporting drug designing in dengue. Most are relevant and sharing the knowledge about the Flavivirus and the cell infection mechanism but yet except some of the leading pharma industries no plant based antiviral drug development is initiated. In the present day, there are no drugs against dengue as far as stated (Halstead, 2008; Gubler et al., 2007; Noble et al., 2010).

DENV having the Non-structural protein 3 (NS3) is responsible for proteolysis of the dengue viral RNA polyprotein as well as carrying out various enzymatic reactions that are mandatory for replication of the dengue virus. In addition, NS5 can stimulate the NTPase activity of NS3 which is necessary for unwinding of dsRNA substrates by helicase activity during viral replication. Arakaki et al. (2002) and Salonen et al. (2005) hence, the different non-structural dengue proteins were selected as a target which always plays a role in viral replication. Therefore, C. papaya was selected for evaluation of its natural antiviral active compounds. Previous studies stated the medicinal properties of the plant against dengue at pathological level but without scientific evidence. Since, the ancient times, C. papaya recommended for viral infection, wound healing etc. Hence, this in silico attempt was made to elucidate the mechanism and to develop a hypothesis explaining inhibitory activity of compounds available in C. papaya against virus at cellular level (Saklani and Kutty, 2008, Ayoola and Adeyeye, 2010; Dawkins et al., 2003; Cowan, 1999).

Current docking results confirms that isolated compounds having medicinal properties and can bind more effectively with the respective targets in dengue virus type 2. Among the 8 compounds 3 show promising result against the NS3 and NS5 proteins. 2-Methoxy-4-vinylphenol, 9, 12, 15-Octadecatrienoic acid, (Z,Z,Z) interact with pockets available in target proteins. Both the compounds interact mainly with RNA dependent polymerase which directly inhibits the viral replication. This would open the doors for new drug discovery and drug development in the field of dengue. The proteomics based studies are important in targeted drug delivery system hence this study reveals the docking part after the complete proteomics of targeted proteins of dengue virus.

Dengue has emerged as a most important viral infection in the 21st century. The complexity of dengue infection and the difficulties in vaccine design has prompted us to study the role of antiviral compounds in C. papaya. The crude extract of the plant has been used in treatment of dengue however, without enough scientific evidence. This study will throw some light on the antiviral role of the compounds present in the extract which will play an important role in drug development.

Arakaki, T.L., N.X. Fang, D.P. Fairlie, P.R. Young and J.L. Martin, 2002. Catalytically active dengue virus NS3 protease forms aggregates that are separable by size exclusion chromatography. Protein Expression Purif., 25: 241-247.
CrossRef  |  Direct Link  |  

Ayoola, P.B. and A. Adeyeye, 2010. Phytochemical and nutrient evaluation of Carica papaya (pawpaw) leaves. Int. J. Res. Rev. Applied Sci., 5: 325-328.
Direct Link  |  

Bhattacharjee, A. and D. Bhattacharjee, 2011. A Bayesian approach to compare the statewise dengue death counts in India. Int. J. Collaborative Res. Internal Med. Public Health, 3: 715-723.
Direct Link  |  

Bikadi, Z. and E. Hazai, 2009. Application of the PM6 semi-empirical method to modeling proteins enhances docking accuracy of AutoDock. J. Cheminform., Vol. 1. 10.1186/1758-2946-1-15

Cheng, F., W. Li, Y. Zhou, J. Shen and Z. Wu et al., 2012. admetSAR: A comprehensive source and free tool for assessment of chemical ADMET properties. J. Chem. Inform. Model., 52: 3099-3105.
CrossRef  |  Direct Link  |  

Cowan, M.M., 1999. Plant products as antimicrobial agents. Clin. Microbiol. Rev., 12: 564-582.
CrossRef  |  PubMed  |  Direct Link  |  

Dawkins, G., H. Hewitt, Y. Wint, P.C. Obiefuna and B. Wint, 2003. Antibacterial effects of Carica papaya fruit on common wound organisms. West Indian Med. J., 52: 290-292.
PubMed  |  

Erbel, P., N. Schiering, A. D'Arcy, M. Renatus and M. Kroemer et al., 2006. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus. Nat. Struct. Mol. Biol., 13: 372-373.
CrossRef  |  Direct Link  |  

Gross, D., 2003. Papaya: A tantalising taste of the tropics. Maricopa County Master Gardener Volunteer information, University of Arizona Cooperative Extension.

Gubler, D., G. Kuno and L. Markoff, 2007. Flaviviruses. In: Fields Virology, Knipe, D.M. and P.M. Howley (Eds.). Vol. 1, 5th Edn., Lippincott Williams and Wilkins, Philadelphia, PA., USA., pp: 1163-1252.

Gupta, N., S. Srivastava, A. Jain and U.C. Chaturvedi, 2012. Dengue in India. Indian J. Med. Res., 136: 373-390.
PubMed  |  Direct Link  |  

Halstead, S.B., 2008. Dengue virus-mosquito interactions. Ann. Rev. Entomol., 53: 273-291.
CrossRef  |  Direct Link  |  

Lipinski, C.A., F. Lombardo, B.W. Dominy and P.J. Feeney, 1997. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Delivery Rev., 23: 3-25.
CrossRef  |  

Murthy, H.M.K., S. Clum and R. Padmanabhan, 1999. Dengue virus NS3 serine protease. Crystal structure and insights into interaction of the active site with substrates by molecular modeling and structural analysis of mutational effects. J. Biol. Chem., 274: 5573-5580.
PubMed  |  

Noble, C.G., Y.L. Chen, H. Dong, F. Gu and S.P. Lim et al., 2010. Strategies for development of dengue virus inhibitors. Antiviral Res., 85: 450-462.
CrossRef  |  Direct Link  |  

Ocloo, A., N.C. Nwokolo and N.T.K.D. Dayie, 2012. Phytochemical characterization and comparative efficacies of crude extracts of Carica papaya. Int. J. Drug Res. Technol., 2: 399-406.
Direct Link  |  

Saklani, A. and S.K. Kutty, 2008. Plant-derived compounds in clinical trials. Drug Discov. Today, 13: 161-171.
CrossRef  |  PubMed  |  

Salonen, A., T. Ahola and L. Kaariainen, 2005. Viral RNA replication in association with cellular membranes. Curr. Top. Microbiol. Immunol., 285: 139-173.
PubMed  |  

Solis, F.J. and R.J.B. Wets, 1981. Minimization by random search techniques. Math. Oper. Res., 6: 19-30.
Direct Link  |  

WHO, 2009. Dengue Guidelines for Diagnosis, Treatment, Prevention and Control. World Health Organization, Geneva, Switzerland, ISBN-13: 9789241547871, Pages: 147.

©  2020 Science Alert. All Rights Reserved